These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33614163)

  • 1. Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis.
    Nagai K
    Ren Replace Ther; 2021; 7(1):8. PubMed ID: 33614163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis.
    Peraldi MN; Berrou J; Métivier F; Toubert A
    Blood Purif; 2013; 35 Suppl 2():14-9. PubMed ID: 23676830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients.
    Peraldi MN; Berrou J; Dulphy N; Seidowsky A; Haas P; Boissel N; Metivier F; Randoux C; Kossari N; Guérin A; Geffroy S; Delavaud G; Marin-Esteban V; Glotz D; Charron D; Toubert A
    J Immunol; 2009 Feb; 182(3):1696-705. PubMed ID: 19155520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.
    Alves-Peixoto P; Férez M; Knudson CJ; Stotesbury C; Melo-Silva CR; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients.
    Gascon A; Orfao A; Lerma JL; Ciudad J; Lopez A; Hernandez MD; Tabernero JM
    Am J Kidney Dis; 1996 Mar; 27(3):373-9. PubMed ID: 8604706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed natural killer cell activity in uremia. Evidence for immunosuppressive factor in uremic sera.
    Asaka M; Iida H; Izumino K; Sasayama S
    Nephron; 1988; 49(4):291-5. PubMed ID: 3261845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
    García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T
    PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.
    De Pelsmaeker S; Dierick E; Klupp B; Mettenleiter TC; Cantoni C; Vitale M; Favoreel HW
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
    Blood Purif; 2008; 26(4):317-21. PubMed ID: 18463433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping of Natural Killer Cell Antitumor Activity by
    Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
    Front Immunol; 2017; 8():458. PubMed ID: 28491060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.
    Gröschel C; Hübscher D; Nolte J; Monecke S; Sasse A; Elsner L; Paulus W; Trenkwalder C; Polić B; Mansouri A; Guan K; Dressel R
    Front Immunol; 2017; 8():870. PubMed ID: 28890717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.
    Tomchuck SL; Leung WH; Dallas MH
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):39-49. PubMed ID: 25464114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans.
    Voss M; Bryceson YT
    Clin Immunol; 2017 Apr; 177():29-42. PubMed ID: 26592356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection.
    Rajalingam R
    Front Immunol; 2016; 7():585. PubMed ID: 28066408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
    Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
    Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.